Clinical Trial Update: Pharmacokinetics of Alisertib in Adults With Advanced Solid Tumors or Relapsed/Refractory Lymphoma With Varying Degrees of Hepatic Function [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study of alisertib in adults with advanced solid tumors or relapsed/refractory lymphoma across varying hepatic function; results comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Or Refractory Lymphoma
• Solid Tumors

Drugs mentioned

• Alisertib (alisertib)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Advanced Solid Tumors, Relapsed/Refractory Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2018-11-15